{"id":"NCT03740919","sponsor":"Eli Lilly and Company","briefTitle":"A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes","officialTitle":"A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-07","primaryCompletion":"2021-07-02","completion":"2021-07-02","firstPosted":"2018-11-14","resultsPosted":"2022-01-24","lastUpdate":"2022-01-24"},"enrollment":751,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"LY900014","otherNames":["Ultra-Rapid Lispro"]},{"type":"DRUG","name":"Insulin Lispro","otherNames":["Humalog","LY275585"]},{"type":"DRUG","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"Insulin Degludec","otherNames":[]}],"arms":[{"label":"Insulin Lispro (Humalog)","type":"ACTIVE_COMPARATOR"},{"label":"LY900014","type":"EXPERIMENTAL"},{"label":"LY900014 Postmeal","type":"EXPERIMENTAL"}],"summary":"The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) Efficacy Estimand at Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"Insulin Lispro (Humalog)","deltaMin":0.09,"sd":0.052},{"arm":"LY900014","deltaMin":0.06,"sd":0.054}],"pValues":[{"comp":"OG000 vs OG001","p":"0.783"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":111,"countries":["United States","Austria","Brazil","China","Czechia","Denmark","France","Germany","Israel","Italy","Japan","Mexico","Poland","Puerto Rico","Russia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/3msKrLw2I0WuYqosKQw22Q"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":751},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Rhinitis","Vomiting"]}}